🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Optimind Pharma Corp. (CSE:OMND)
Canada flag Canada · Delayed Price · Currency is CAD
0.0050
0.00 (0.00%)
At close: Sep 11, 2025

Optimind Pharma Income Statement

Millions CAD. Fiscal year is Mar - Feb.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
0.090.120.120.120.170.1
Revenue Growth
-26.11%2.47%-3.73%-27.72%70.64%-
Cost of Revenue
0.040.050.050.060.120.04
Gross Profit
0.050.080.070.060.050.06
Selling, General & Admin
0.120.120.270.510.920.44
Research & Development
---0.12--
Amortization of Goodwill & Intangibles
----0.010.01
Operating Expenses
0.120.120.270.810.960.47
Operating Income
-0.06-0.04-0.2-0.75-0.91-0.4
Interest Expense
----0.09-0.07-0.02
Other Non Operating Income (Expenses)
-0.02-0.03-0.01-0.21-0.03-
EBT Excluding Unusual Items
-0.09-0.07-0.22-1.05-1.01-0.42
Impairment of Goodwill
-----0.86-
Gain (Loss) on Sale of Investments
-0.05-0.05---0.31-
Asset Writedown
----0.37-0.65-
Other Unusual Items
---0.02-0.26-
Pretax Income
-0.14-0.12-0.22-1.41-3.09-0.42
Income Tax Expense
----0.01-0.01-0.14
Net Income
-0.14-0.12-0.22-1.4-3.08-0.28
Net Income to Common
-0.14-0.12-0.22-1.4-3.08-0.28
Net Income Growth
------
Shares Outstanding (Basic)
1031041111008244
Shares Outstanding (Diluted)
1031041111008244
Shares Change
-4.25%-7.14%12.00%21.38%88.09%-
EPS (Basic)
-0.00-0.00-0.00-0.01-0.04-0.01
EPS (Diluted)
-0.00-0.00-0.00-0.01-0.04-0.01
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
Gross Margin
59.53%62.33%58.27%47.63%30.49%63.89%
Operating Margin
-70.90%-35.27%-170.38%-612.59%-533.41%-405.39%
Profit Margin
-149.48%-97.23%-182.32%-1136.63%-1809.57%-278.57%
EBITDA
----0.74-0.89-0.39
D&A For EBITDA
---0.010.010.01
EBIT
-0.06-0.04-0.2-0.75-0.91-0.4
EBIT Margin
-70.90%-35.27%-170.38%---